ESTRO 2024 - Abstract Book

S2217

Clinical - Upper GI

ESTRO 2024

Conclusion:

Our NTCP-model, supported by voxel based analysis, indicates that LVD is related to the risk of developing postoperative cardiac complications in esophageal cancer trimodality therapy. Trying to lower dose the LVD could pose a valid strategy in reducing these complications.

Keywords: Esophageal cancer, Cardiac complications

1954

Proffered Paper

Adjuvant Stereotactic Pancreatic Radiotherapy (SPARTA trial): preliminary toxicity results

Maria Massaro 1 , Tiziana Comito 1 , Maria Ausilia Teriaca 1 , Ciro Franzese 1,2 , Veronica Vernier 1,2 , Marco Antonio Marzo 1,2 , Lucia Paganini 1 , Francesco La Fauci 1 , Stefano Tomatis 1 , Marta Scorsetti 2,1 1 IRCCS Humanitas Research Hospital, Radiotherapy and Radiosurgery Department, Rozzano, Italy. 2 Humanitas University, Department of Biomedical Sciences, Pieve Emanuele, Italy

Purpose/Objective:

This preliminary analysis aims to assess toxicity profile of an ongoing phase II prospective study (NCT05043857) evaluating the impact of adjuvant stereotactic body radiation therapy (SBRT) after surgery of pancreatic cancer with high risk features (SPARTA trial), with the purpose of deliver a dose-intensive treatment in a shorter time allowing better integration of chemotherapy (ChT) and surgery.